These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34343576)
1. Centralization of multisite reagent lot-to-lot validation for Ortho Clinical Vitros chemistry instruments. To M; Raizman JE; Goudreau BL; Higgins T; Brun M; Tsui AKY Clin Biochem; 2021 Nov; 97():62-66. PubMed ID: 34343576 [TBL] [Abstract][Full Text] [Related]
2. Statistical validation of reagent lot change in the clinical chemistry laboratory can confer insights on good clinical laboratory practice. Cho MC; Kim SY; Jeong TD; Lee W; Chun S; Min WK Ann Clin Biochem; 2014 Nov; 51(Pt 6):688-94. PubMed ID: 24497612 [TBL] [Abstract][Full Text] [Related]
3. Sample size and rejection limits for detecting reagent lot variability: analysis of the applicability of the Clinical and Laboratory Standards Institute (CLSI) EP26-A protocol to real-world clinical chemistry data. Kim S; Chang J; Kim SK; Park S; Huh J; Jeong TD Clin Chem Lab Med; 2020 Jul; 59(1):127-138. PubMed ID: 32628625 [TBL] [Abstract][Full Text] [Related]
4. Commutability limitations influence quality control results with different reagent lots. Miller WG; Erek A; Cunningham TD; Oladipo O; Scott MG; Johnson RE Clin Chem; 2011 Jan; 57(1):76-83. PubMed ID: 21097677 [TBL] [Abstract][Full Text] [Related]
6. Failure of current laboratory protocols to detect lot-to-lot reagent differences: findings and possible solutions. Algeciras-Schimnich A; Bruns DE; Boyd JC; Bryant SC; La Fortune KA; Grebe SK Clin Chem; 2013 Aug; 59(8):1187-94. PubMed ID: 23592508 [TBL] [Abstract][Full Text] [Related]
7. Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey. Rutledge AC; Johnston A; Booth RA; Veljkovic K; Bailey D; Vandenberghe H; Waite G; Allen LC; Don-Wauchope A; Chan PC; Stemp J; Edmond P; Leung V; Aslan B Pract Lab Med; 2022 Nov; 32():e00300. PubMed ID: 36035320 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the CLSI EP26-A protocol for detection of reagent lot-to-lot differences. Katzman BM; Ness KM; Algeciras-Schimnich A Clin Biochem; 2017 Sep; 50(13-14):768-771. PubMed ID: 28322754 [TBL] [Abstract][Full Text] [Related]
9. Research and discussion on the evaluation scheme of reagent lot-to-lot differences in 16 chemiluminescence analytes, established by the EP26-A guidelines of the CLSI. Tao R; Zhang C; Liu M; Yang M; Gao W; Chen J; Mo N; Cheng Y; He J; Xie Q J Clin Lab Anal; 2021 Mar; 35(3):e23675. PubMed ID: 33274497 [TBL] [Abstract][Full Text] [Related]
10. A model for managing quality control for a network of clinical chemistry instruments measuring the same analyte. Giannoli JM; Bernard M; L'Hirondel J; Heim A; Badrick T Clin Chem Lab Med; 2024 Apr; 62(5):853-860. PubMed ID: 37999926 [TBL] [Abstract][Full Text] [Related]
11. Methods Comparison and Bias Estimation of Three Distinct Biochemistry Analytical Systems in One Clinical Laboratory Using Patient Samples. Fu H; Yan S; Wang Y; Gu D; Li X; Yang G; Liu Y Clin Lab; 2016; 62(1-2):187-94. PubMed ID: 27012049 [TBL] [Abstract][Full Text] [Related]
12. Analysis of reagent lot-to-lot comparability tests in five immunoassay items. Kim HS; Kang HJ; Whang DH; Lee SG; Park MJ; Park JY; Lee KM Ann Clin Lab Sci; 2012; 42(2):165-73. PubMed ID: 22585613 [TBL] [Abstract][Full Text] [Related]
13. Establishing a simple and sustainable quality assurance program and clinical chemistry services in Eritrea. Scott MG; Morin S; Hock KG; Seyoum M; Ladenson JH Clin Chem; 2007 Nov; 53(11):1945-53. PubMed ID: 17954496 [TBL] [Abstract][Full Text] [Related]
14. Practical Considerations for Clinical Laboratories in Top-down Approach for Assessing the Measurement Uncertainty of Clinical Chemistry Analytes. Gu H; Lee J; Hong J; Lee W; Yun YM; Chun S; Lee WI; Min WK Ann Lab Med; 2022 Nov; 42(6):630-637. PubMed ID: 35765871 [TBL] [Abstract][Full Text] [Related]
15. Performance characteristics of automated clinical chemistry analyzers using commercial assay reagents contributing to quality assurance and clinical decision in a hospital laboratory. Tzortzopoulos A; Raftopoulos V; Talias MA Scand J Clin Lab Invest; 2020 Feb; 80(1):46-54. PubMed ID: 31766906 [No Abstract] [Full Text] [Related]
16. Achieving accuracy for routine clinical chemistry methods by using patient specimen correlations to assign calibrator values. A means of managing matrix effects. Lasky FD Arch Pathol Lab Med; 1993 Apr; 117(4):412-9. PubMed ID: 8466405 [TBL] [Abstract][Full Text] [Related]
17. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies. Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549 [TBL] [Abstract][Full Text] [Related]
18. Analysis of short-term variation and long-term drift during reagent kit lot change in an NABL accredited clinical biochemistry laboratory. Ambade V; Misra P; Vashum Y; Sharma M; Mukherjee B; Bhatia K; Puliyath M; Rasu P; Indra PB; Sibin MK J Med Biochem; 2021 Jan; 40(1):92-98. PubMed ID: 33584145 [TBL] [Abstract][Full Text] [Related]